Drafter, I agree that this is a good move by Benitec, especially if they combine the CAR T and stem cells research in the first instance. I only hope that we don't stretch our limited funds too far. With no other program being close to getting into the clinic, so much is riding on the TT-034 results. However, you get the feeling that, if we just got a little crack in the funding dam, the flood would break through.
BLT Price at posting:
80.0¢ Sentiment: None Disclosure: Held